Impact of VM-20 on life insurance product development: Phase 2

  • Print
  • Connect
  • Email
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
By Paul M. Fedchak, Jacqueline M. Keating, Karen K. Rudolph, Uri Sobel, Andrew Steenman | 14 August 2017

Phase 2 of this research report expands on the Phase 1 case studies for term and universal life with secondary guarantees (ULSG) products and includes additional case studies focused on smaller companies and the impact of reinsurance. It also discusses the industry’s preparedness for pricing under VM-20 and identifies pricing and product design issues through interviews and discussions with product development actuaries.

This article was published by the Society of Actuaries.

Read or print the article